Skip to main content
Caplight Logo









Heligenics, Inc.

Heligenics, Inc.

Private
Las Vegas, NevadaHealthcare & Life Scienceshttps://www.heligenics.com/

Last Round

Grant

Feb 1, 2025

Total Funding Raised

$4.55M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Heligenics, Inc. is a biotechnology company that provides functional genomics research and drug discovery services using its proprietary GigaAssay™ technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

functional genomicsdrug discoverydrug discovery platformhigh-throughput screeningbiologic drugprecision medicinevariant librarybiosimilarsbiobettersclinical trial stratificationwet-labdrug optimizationbiotech servicesgenomic datade-risking drug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Heligenics, Inc. Comparables

Compare Heligenics, Inc. with similar companies based on industry and business-model similarity.

Heligenics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Constantiam Biosciences
86%
Atlas Biotech
83%
Algen Biotechnologies
78%

Heligenics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2025
SeedJun 9, 2022
SeedDec 15, 2020

Key People

Founding team and executive leadership

Martin R. Schiller

Chairman, CEO

Executive Team

Heligenics, Inc. Investors

Notable investors and investment history

Heligenics, Inc. investors
InvestorRounds
National Institutes of Health (NIH)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors grew 364% MoM, reaching 1.9K.

  • Jan 6, 2026

    Monthly visitors grew 643% MoM, reaching 3.2K.

Heligenics, Inc. Filings

Explore SEC and related filing metadata, where available.

Heligenics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Heligenics, Inc.'s valuation, stock price, and market status.

Is Heligenics, Inc. a public or private company?

Heligenics, Inc. is a private company.

What is the current stock price of Heligenics, Inc.?

Heligenics, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Heligenics, Inc. worth (valuation)?

Valuation information for Heligenics, Inc. is not publicly available.

Can I buy Heligenics, Inc. stock?

Heligenics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Heligenics, Inc.'s last funding round?

Funding round information for Heligenics, Inc. is not publicly available.

Who are the main investors in Heligenics, Inc.?

Investor information for Heligenics, Inc. is not publicly disclosed.

Will Heligenics, Inc. IPO soon?

No public IPO plans have been announced for Heligenics, Inc..

How can I track Heligenics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Heligenics, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLas Vegas, Nevada
Employee Range7
Year Founded2019
Last FundingFeb 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?